Top

BMC Pregnancy and Childbirth

Published in:

Open Access 01-12-2018 | Research article

Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia

Authors: Solomon Assefa, Kassu Desta, Tsehaynesh Lema

Published in: BMC Pregnancy and Childbirth | Issue 1/2018

Abstract

Background

Group B Streptococcus (GBS) is the leading cause of septicemia, meningitis, and pneumonia in neonates. Maternal colonization with GBS is the principal risk factor for early-onset disease in infants. Group B Streptococcus is now an important cause of maternal and neonatal morbidity and mortality in many parts of the world. In Ethiopia, few studies have been done on GBS colonization among pregnant women. The aim of this study was to determine the prevalence of GBS colonization, antimicrobial susceptibility patterns and assess risk factors among pregnant women.

Methods

A prospective cross-sectional study was conducted from May to August 2014 at selected public antenatal care (ANC) centers in Addis Ababa, Ethiopia. Clinical and socio-demographical data were collected using structured questionnaire after obtaining written informed consent. A total of 281 lower vaginal swabs were collected and inoculated into 1 ml Todd Hewitt Broth supplemented with gentamicin and nalidixic acid to prevent the growth of contaminants. After overnight incubation, all broths were subcultured on 5% sheep blood agar for isolation of GBS. Antimicrobial susceptibility testing was performed according to the criteria of the Clinical and Laboratory Standard Institute (CLSI) guidelines 2013 by disk diffusion method. Data were entered and analysed using SPSS version 20.0 software. Chi-square test and binary logistic regression analysis were used. P-value < 0.05 was considered statistically significant.

Results

The overall prevalence of GBS colonization among pregnant women was 14.6% (41/281). Group B Streptococcus colonization was significantly associated with health institutions (P < 0.05). All GBS isolates were susceptible to chloramphenicol. Resistance to tetracycline, cefotaxime, clindamycin, penicillin, vancomycin, ampicillin and erythromycin was 90.2%, 34.1, 26.8%, 19.5, 17%, 14.6 and 7.5% respectively. Multidrug resistance (MDR) (≥ 2 drugs) was detected in 43.9% (18/41) of the isolates.

Conclusion

There was a high frequency of GBS colonization (14.6%) and resistance to the commonly used antibiotics which suggests the importance of the screening of GBS colonization in pregnant women at 35–37 weeks of gestation and testing their antimicrobial susceptibilities in order to provide antibiotic prophylaxis and minimize newborn infection and co-morbidity.

Phares CR, Lynfield R, Farley MM, Mohle-Boetani J, Harrison LH, Petit S, et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. JAMA. 2008;299(17):2056–65. https://doi.org/10.1001/jama.299.17.2056.CrossRefPubMed

Committee on Infectious Diseases and Committee on Fetus and Newborn, Baker CJ, Byington CL, Polin RA. Policy Statement - Recommendations for the prevention of perinatal group B streptococcal (GBS) disease. Pediatrics. 2011;128(3):611–6. https://doi.org/10.1542/peds.2011-1466.

Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease: Revised guidelines from CDC, 2010: Department of Health and Human Services, Centers for Disease Control and Prevention,2010 Nov 19 Contract No.: RR-10.

Faro S, Brehm B, Smith F, Mouzoon M, Greisinger A, Wehmanen O, et al. Screening for group B streptococcus: a private hospital's experience. Infect Dis Obstet Gynecol. 2010;2010:1–4. https://doi.org/10.1155/2010/451096.CrossRef

Maisey HC, Doran KS, Nizet V. Recent advances in understanding the molecular basis of group B Streptococcus virulence. Expert Rev Mol Med. 2008;10:e27. https://doi.org/10.1017/S1462399408000811.CrossRefPubMedPubMedCentral

Joachim A, Matee MI, Massawe FA, Lyamuya EF. Maternal and neonatal colonisation of group B streptococcus at Muhimbili National Hospital in Dar es salaam, Tanzania: prevalence, risk factors and antimicrobial resistance. BMC Public Health. 2009;9:437. https://doi.org/10.1186/1471-2458-9-437.CrossRefPubMedPubMedCentral

Ezeonu I, Agbo M. Incidence and anti-microbial resistance profile of group B Streptococcus (GBS) infection in pregnant women in Nsukka, Enugu state, Nigeria. Afr J Microbiol Res. 2014;8(1):91–5. https://doi.org/10.5897/AJMR12.2307. CrossRef

El Beitune P, Duarte G, Maffei CM. Colonization by Streptococcus agalactiae during pregnancy: maternal and perinatal prognosis. Braz J Infect Dis. 2005;9(4):276–82. doi:/S1413–86702005000400002CrossRefPubMed

El Aila NA, Tency I, Claeys G, Saerens B, Cools P, Verstraelen H, et al. Comparison of different sampling techniques and of different culture methods for detection of group B streptococcus carriage in pregnant women. BMC Infect Dis. 2010;10:285. https://doi.org/10.1186/1471-2334-10-285.CrossRefPubMedPubMedCentral

10.

Cheng PJ, Chueh HY, Liu CM, Hsu JJ, Hsieh TT, Soong YK. Risk factors for recurrence of group B streptococcus colonization in a subsequent pregnancy. Obstet Gynecol. 2008;111(3):704–9. https://doi.org/10.1097/AOG.0b013e318163cd6b.CrossRefPubMed

11.

Schmidt J, Halle E, Halle H, Mohammed T, Gunther E. Colonization of pregnant women and their newborn infants with group B streptococci in the Gondar College of Medical Sciences. Ethiop Med J. 1989;27(3):115–9.PubMed

12.

Mohammed M, Asrat D, Woldeamanuel Y, Demissie A. Prevalence of group B Streptococcus colonization among pregnant women attending antenatal clinic of Hawassa health center, Hawassa, Ethiopia. Ethiop J Health Dev. 2012;26(1):36–42.

13.

American College of O, Gynecologists Committee on Obstetric P. ACOG Committee Opinion No. 485: Prevention of early-onset group B streptococcal disease in newborns. Obstet Gynecol Annu. 2011;117(4):1019–27. https://doi.org/10.1097/AOG.0b013e318219229b.CrossRef

14.

Cockerill FR. Performance standards for antimicrobial susceptibility testing: twenty-third informational supplement. Clinical Laboratory Standards Institute; 2013.

15.

Onipede A, Adefusi O, Adeyemi A, Adejuyigbe E, Oyelese A, Ogunniyi T. Group B streptococcus carriage during late pregnancy in Ile-Ife, Nigeria. Afr J Clin Exp Microbiol. 2012;13(3):135–43.

16.

Dzowela T, Komolafe O, Igbigbi A. Prevalence of group B Streptococcus colonization in antenatal women at the queen Elizabeth central hospital, Blantyre–a preliminary study. Malawi Med J. 2006;17(3):97–9.CrossRef

17.

De Steenwinkel FD, Tak HV, Muller AE, Nouwen JL, Oostvogel PM, Mocumbi SM. Low carriage rate of group B streptococcus in pregnant women in Maputo, Mozambique. Tropical Med Int Health. 2008;13(3):427–9. https://doi.org/10.1111/j.1365-3156.2008.02018.x.CrossRef

18.

Mavenyengwa RT, Afset JE, Schei B, Berg S, Caspersen T, Bergseng H, et al. Group B Streptococcus colonization during pregnancy and maternal-fetal transmission in Zimbabwe. Acta Obstet Gynecol Scand. 2010;89(2):250–5. https://doi.org/10.3109/00016340903398029.CrossRefPubMed

19.

Busetti M, D'Agaro P, Campello C. Group B streptococcus prevalence in pregnant women from north-eastern Italy: advantages of a screening strategy based on direct plating plus broth enrichment. J Clin Pathol. 2007;60(10):1140–3. https://doi.org/10.1136/jcp.2006.043489.CrossRefPubMed

20.

Savoia D, Gottimer C, Crocilla C, Zucca M. Streptococcus agalactiae in pregnant women: phenotypic and genotypic characters. J Inf Secur. 2008;56(2):120–5. https://doi.org/10.1016/j.jinf.2007.11.007.

21.

Strus M, Pawlik D, Brzychczy-Wloch M, Gosiewski T, Rytlewski K, Lauterbach R, et al. Group B streptococcus colonization of pregnant women and their children observed on obstetric and neonatal wards of the University Hospital in Krakow, Poland. J Med Microbiol. 2009;58(2):228–33. https://doi.org/10.1099/jmm.0.002865-0.CrossRefPubMed

22.

Tsolia M, Psoma M, Gavrili S, Petrochilou V, Michalas S, Legakis N, et al. Group B streptococcus colonization of Greek pregnant women and neonates: prevalence, risk factors and serotypes. Clin Microbiol Infect. 2003;9(8):832–8.CrossRefPubMed

23.

Rausch AV, Gross A, Droz S, Bodmer T, Surbek DV. Group B streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis. J Perinat Med. 2009;37(2):124–9. https://doi.org/10.1515/JPM.2009.020. CrossRefPubMed

24.

Jones N, Oliver K, Jones Y, Haines A, Crook D. Carriage of group B streptococcus in pregnant women from Oxford, UK. J Clin Pathol. 2006;59(4):363–6. https://doi.org/10.1136/jcp.2005.029058.CrossRefPubMedPubMedCentral

25.

Valkenburg-van den Berg AW, Sprij AJ, Oostvogel PM, Mutsaers JA, Renes WB, Rosendaal FR, et al. Prevalence of colonisation with group B streptococci in pregnant women of a multi-ethnic population in the Netherlands. Eur J Obstet Gynecol Reprod Biol. 2006;124(2):178–83. https://doi.org/10.1016/j.ejogrb.2005.06.007.CrossRefPubMed

26.

Chohan L, Hollier LM, Bishop K, Kilpatrick CC. Patterns of antibiotic resistance among group B streptococcus isolates: 2001-2004. Infect Dis Obstet Gynecol. 2006;2006:57492. https://doi.org/10.1155/IDOG/2006/57492.CrossRefPubMedPubMedCentral

27.

Zusman AS, Baltimore RS, Fonseca SN. Prevalence of maternal group B streptococcal colonization and related risk factors in a Brazilian population. Braz J Infect Dis. 2006;10(4):242–6.CrossRefPubMed

28.

Simoes JA, Alves VM, Fracalanzza SE, de Camargo RP, Mathias L, Milanez HM, et al. Phenotypical characteristics of group B streptococcus in parturients. Braz J Infect Dis. 2007;11(2):261–6.CrossRefPubMed

29.

Costa AL, Lamy Filho F, Chein MB, Brito LM, Lamy ZC, Andrade KL. Prevalence of colonization by group B Streptococcus in pregnant women from a public maternity of northwest region of Brazil. Rev Bras Ginecol Obstet. 2008;30(6):274–80.CrossRefPubMed

30.

Quiroga M, Pegels E, Oviedo P, Pereyra E, Vergara M. Antibiotic susceptibility patterns and prevalence of group B Streptococcus isolated from pregnant women in Misiones, Argentina. Braz J Microbiol. 2008;39(2):245–50. https://doi.org/10.1590/S1517-83822008000200009.CrossRefPubMedPubMedCentral

31.

Yang MJ, Sun PL, Wen KC, Chao KC, Chang WH, Chen CY, et al. Prevalence of maternal group B streptococcus colonization and vertical transmission in low-risk women in a single institute. J Chin Med Assoc. 2012;75(1):25–8. https://doi.org/10.1016/j.jcma.2011.10.011.CrossRefPubMed

32.

Sharmila V, Joseph NM, Arun Babu T, Chaturvedula L, Sistla S. Genital tract group B streptococcal colonization in pregnant women: a south Indian perspective. J Infect Dev Ctries. 2011;5(8):592–5. https://doi.org/10.3855/jidc.1551. PubMed

33.

Lu B, Li D, Cui Y, Sui W, Huang L, Lu X. Epidemiology of group B streptococcus isolated from pregnant women in Beijing. China Clin Microbiol Infect. 2014;20(6):370–3. https://doi.org/10.1111/1469-0691.12416.CrossRef

34.

Kim EJ, Oh KY, Kim MY, Seo YS, Shin JH, Song YR, et al. Risk factors for group B streptococcus colonization among pregnant women in Korea. Epidemiol Health. 2011;33:1–7. https://doi.org/10.4178/epih/e2011010.

35.

Gray KJ, Kafulafula G, Matemba M, Kamdolozi M, Membe G, French N. Group B Streptococcus and HIV infection in pregnant women, Malawi, 2008-2010. Emerg Infect Dis. 2011;17(10):1932–5. https://doi.org/10.3201/eid1710.102008.CrossRefPubMedPubMedCentral

36.

Mitima KT, Ntamako S, Birindwa AM, Mukanire N, Kivukuto JM, Tsongo K, et al. Prevalence of colonization by Streptococcus agalactiae among pregnant women in Bukavu, Democratic Republic of the Congo. J Infect Dev Ctries. 2014;8(9):1195–200. https://doi.org/10.3855/jidc.5030. CrossRefPubMed

37.

Orrett FA. Colonization with group B streptococci in pregnancy and outcome of infected neonates in Trinidad. Pediatr Int. 2003;45(3):319–23.CrossRefPubMed

38.

Wang H, Zhao C, He W, Zhang F, Zhang L, Cao B, et al. High prevalence of fluoroquinolone-resistant group B streptococci among clinical isolates in China and predominance of sequence type 19 with serotype III. Antimicrob Agents Chemother. 2013;57(3):1538–41. https://doi.org/10.1128/AAC.02317-12.CrossRefPubMedPubMedCentral

39.

Capanna F, Emonet SP, Cherkaoui A, Irion O, Schrenzel J, Martinez de Tejada B. Antibiotic resistance patterns among group B Streptococcus isolates: implications for antibiotic prophylaxis for early-onset neonatal sepsis. Swiss Med Wkly. 2013;143:1–4. https://doi.org/10.4414/smw.2013.13778.

40.

DiPersio LP, DiPersio JR. High rates of erythromycin and clindamycin resistance among OBGYN isolates of group B Streptococcus. Diagn Microbiol Infect Dis. 2006;54(1):79–82. https://doi.org/10.1016/j.diagmicrobio.2005.07.003.CrossRefPubMed

41.

Yook JH, Kim MY, Kim EJ, Yang JH, Ryu HM, Oh KY, et al. Risk factors associated with group B streptococcus resistant to clindamycin and erythromycin in pregnant korean women. Infect Chemother. 2013;45(3):299–307. https://doi.org/10.3947/ic.2013.45.3.299.CrossRefPubMedPubMedCentral

42.

Boswihi SS, Udo EE, Al-Sweih N. Serotypes and antibiotic resistance in group B streptococcus isolated from patients at the maternity hospital, Kuwait. J Med Microbiol. 2012;61(1):126–31. https://doi.org/10.1099/jmm.0.035477-0.CrossRefPubMed

43.

Castellano-Filho DS, da Silva VL, Nascimento TC, de Toledo Vieira M, Diniz CG. Detection of group B Streptococcus in Brazilian pregnant women and antimicrobial susceptibility patterns. Braz J Microbiol. 2010;41(4):1047–55. https://doi.org/10.1590/S1517-838220100004000024. CrossRefPubMedPubMedCentral

44.

Frohlicher S, Reichen-Fahrni G, Muller M, Surbek D, Droz S, Spellerberg B, et al. Serotype distribution and antimicrobial susceptibility of group B streptococci in pregnant women: results from a Swiss tertiary centre. Swiss Med Wkly. 2014;144:w13935; https://doi.org/10.4414/smw.2014.13935.

45.

Hannoun A, Shehab M, Khairallah MT, Sabra A, Abi-Rached R, Bazi T, et al. Correlation between group B streptococcal genotypes, their antimicrobial resistance profiles, and virulence genes among pregnant women in Lebanon. Int J Microbiol. 2009;2009:1–6. https://doi.org/10.1155/2009/796512.CrossRef

Title: Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia
Authors: Solomon Assefa
Kassu Desta
Tsehaynesh Lema
Publication date: 01-12-2018
Publisher: BioMed Central
Published in: BMC Pregnancy and Childbirth / Issue 1/2018
Electronic ISSN: 1471-2393
DOI: https://doi.org/10.1186/s12884-018-1791-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Group B streptococci vaginal colonization and drug susceptibility pattern among pregnant women attending in selected public antenatal care centers in Addis Ababa, Ethiopia

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2018

Adjunct clinical interventions that influence vaginal birth after cesarean rates: systematic review

Handheld ultrasound to avert maternal and neonatal deaths in 2 regions of the Philippines: an iBuntis® intervention study

Parents’ knowledge, awareness and attitudes of cord blood donation and banking options: an integrative review

Antiepileptic drug exposure in pregnancy and pregnancy outcome from national drug usage data

Creating an Optimality Index – Netherlands: a validation study

Dietary practices and associated factors during pregnancy in northwestern Ethiopia